Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celgene Oncology Strategy: Seizing The Immuno-Hematology Opportunity

Related Content

Celgene Flexes Its Muscles

Mar 01 2011

Celgene’s Budding Blockbuster <em>Abraxane</em> Scoops Pancreatic Cancer Indication

Sep 06 2013

Acute Lymphoblastic Leukemia Poised To Be First, Fast Driver Of CAR Immunotherapy

Feb 19 2014

Celgene Secures <em>Revlimid</em> Frontline Myeloma Approval

Feb 23 2015

Related Companies

Bristol Myers Squibb Company

AstraZeneca PLC

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Merck & Co., Inc.

Roche Holding AG

VentiRx Pharmaceuticals, Inc.

Novartis AG

Kite Pharma, Inc.

Genetix Biotherapeutics

Cellectis SA

Pfizer Inc.

Fred Hutchinson Cancer Research Center

Memorial Sloan Kettering Cancer Center

Seattle Children's Hospital & Medical Center

St. Jude Children's Research Hospital

Additional Topics

Clinical Trials Deals Innovation BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window